WebTranscatheter arterial chemoembolization (TACE) is considered to be one of the most effective palliative measures for patients with inoperable hepatocellular carcinoma (HCC). … WebHence, the ischemic effect due to DC Bead® reflux may continue for more than 3 months and be more severe than that produced by c-TACE . Recently, a case of multi-organ ischemia was described as a consequence of DC Bead® reflux into the gastroduodenal, right gastric, right gastroepiploic, left gastric, and splenic arteries ( 45 ).
CalliSpheres drug-eluting beads versus lipiodol transarterial ...
WebThis randomized trial compares conventional TACE (cTACE) with TACE with DC Bead for the treatment of cirrhotic patients with HCC. Two hundred twelve patients with Child-Pugh A/B cirrhosis and large and/or multinodular, unresectable, N0, M0 HCCs were randomized to receive TACE with DC Bead loaded with doxorubicin or cTACE with doxorubicin. WebJun 3, 2011 · Published data show that TACE is an effective method of treatment for HCC. Early clinical results show that doxorubicin-eluting DC Bead presents higher percentages … dnrme reporting class
Drug-eluting Beads in the Treatment of Cirrhosis
WebRecently, the clinical value of a TACE protocol performed by using the embolic microsphere DC Bead loaded with doxorubicin (DEBDOX; drug-eluting bead doxorubicin) has been shown by randomized controlled trials. An important limitation of conventional TACE has been the inconsistency in the technique and the treatment schedules. WebOct 24, 2024 · The study included 44 hepatocellular carcinoma patients who were treated with TACE using DC Bead LUMI. Beads distribution was monitored 1 h after TACE by CT scan. Results: TACE had no intraprocedural complications. Observed side effects were of mild intensity and included pain in 5 (11%), fever in 4 (9%) and vomiting in 2 (5%) patients. WebApr 13, 2024 · We aimed to investigate the efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) in the treatment of colorectal cancer liver metastasis. A total of 120 patients with colorectal cancer liver metastasis were divided into the TACE group (receiving TACE treatment, n = 60) and the DEB-TACE group (receiving … create me a website